Navigation Links
Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader
Date:10/13/2008

Principal Shareholder Shows Continuing Commitment by Financing All Cash

Transaction Expected to Improve Speed-to-Market for Next Generation

Enterprise PACS

NEW YORK and BIRMINGHAM, Ala., Oct. 13 /PRNewswire-FirstCall/ -- Health Systems Solutions, Inc. (OTC Bulletin Board: HSSO) and Emageon Inc. (Nasdaq: EMAG) today announced the signing of a definitive agreement for HSS to acquire 100% of the stock of Emageon. The agreement was unanimously approved by their respective boards of directors as well as the Strategic Alternatives Committee of Emageon.

Under the terms of the agreement, HSS will acquire all outstanding shares of Emageon common stock for $2.85 a share, in an all cash transaction of approximately $62 million. The price represents approximately a 37% premium on Emageon's share price as of market close on Monday, October 13, 2008.

The consideration for the purchase is being financed by a facility of $85 million provided by Stanford International Bank Ltd, a member of the Stanford Financial Group and HSS' principal shareholder. The additional funds will be used for working capital and to fund growth initiatives. The financing will take the form of 6% Convertible Secured Debentures due 2013 with warrants to purchase up to 9 million shares of common stock.

"This transaction allows HSS to reach critical scale and positions us well for future growth. Our acquisition strategy is based upon using Emageon as our platform acquisition that will enable us to realize synergies from future acquisitions," said Stan Vashovsky, HSS' Chairman and CEO. "This transaction will offer us the ability to leverage Emageon's best-in-market products as well as broaden and strengthen our managemen
'/>"/>

SOURCE Health Systems Solutions, Inc.; Emageon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Nutraceutical to Present at Canaccord Adams Healthy Living Conference
2. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
3. Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health
4. Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT
5. Healthcare Resources Available in Difficult Times
6. Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles
7. CIO Healthcare Summit Announces Dates and VIP Delegates
8. 2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized
9. UNC receives $8.5 million for new public health preparedness research center
10. Free Clinics Now Providing Healthcare Solutions to the Uninsured
11. HealthSouth Announces Plans to Build New Hospital in Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 1New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 2New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 3New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 4Outpatient disc treatment gives long term back pain relief 62403 1Outpatient disc treatment gives long term back pain relief 62403 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 1State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 3